Charles Russell Speechlys advises INEOS on the acquisition of Belstaff
Charles Russell Speechlys has advised INEOS on the acquisition of Belstaff for an undisclosed sum from the fashion label’s owner JAB Holdings, the consumer goods group backed by Germany’s Reimann family.
The acquisition is expected to complete in the fourth quarter of this year, subject to regulatory approvals.
Commenting on the transaction, David Coates, Partner in the Corporate team at Charles Russell Speechlys, said: “We are delighted to have advised INEOS on this transaction and we look forward to hearing what plans INEOS has for this famous British heritage brand”.
The Charles Russell Speechlys core team was led by Corporate Partners David Coates and William Nash assisted by Corporate Associate, Fiona Walsh. Partner, Mark Smith advised on property matters. Partner Paul Henty advised on regulatory matters and Senior Associate Robert Birchall advised on tax.
The Seller was advised by Skadden, Arps, Slate, Meagher & Flom LLP (Linda Davies and Claire Rushton).
News & Insights
Government provides welcome clarity for EMI option holders who have been furloughed
The proposed amendments will provide some clarity and address concerns regarding the consequences of furloughing EMI option holders.
Charles Russell Speechlys advises Transense Technologies Plc on iTrack technology transaction with Bridgestone Corporation
Transense Technologies Plc, the provider of sensor systems for the industrial, mining and transportation markets.
Charles Russell Speechlys advises Kreos and SVB on $70m private placement for AIM listed Mereo BioPharma Group plc
Mereo BioPharma is a clinical stage UK-based biopharmaceutical company listed on the AIM market of the LSE.